Preethi Krishnan, Ph.D. - Publications
Affiliations: | 2000 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
PharmacyYear | Citation | Score | |||
---|---|---|---|---|---|
2001 | Krishnan P, Bastow KF. Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone. Cancer Chemotherapy and Pharmacology. 47: 187-98. PMID 11320661 DOI: 10.1007/S002800000221 | 0.518 | |||
2000 | Krishnan P, Bastow KF. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. Anti-Cancer Drug Design. 15: 255-64. PMID 11200501 | 0.528 | |||
2000 | Krishnan P, Bastow KF. Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives-eleutherin, alpha lapachone, and beta lapachone. Biochemical Pharmacology. 60: 1367-79. PMID 11008131 DOI: 10.1016/S0006-2952(00)00437-8 | 0.57 | |||
2000 | Tachibana Y, Zhu XK, Krishnan P, Lee KH, Bastow KF. Characterization of human lung cancer cells resistant to 4'-O-demethyl-4beta-(2"-nitro-4"-fluoroanilino)-4-desoxypodophyllotoxin , a unique compound in the epipodophyllotoxin antitumor class. Anti-Cancer Drugs. 11: 19-28. PMID 10757559 DOI: 10.1097/00001813-200001000-00004 | 0.518 | |||
Show low-probability matches. |